The Caring Ambassadors supports individuals in gaining control of their healthcare, regardless of the illness they face.

We provide information, tools, and resources to help those with any long-term disease not only manage their health care after a diagnosis, but improve their quality of life and capacity for healing. As an advocacy organization, we both fight for patient rights and work to build a new generation of patient and healthcare champions. Our disease specific programs for Hepatitis C and Lung Cancer have been helping people obtain the support, assistance, and information they need for over 20 years.

Join Us In Salem, OR

Hepatitis Elimination Day!

We need a solid showing in order to secure the money the state needs to treat everyone with hepatitis C.

We have tables available for groups that want to display their work

Are you part of the Elimination movement?

Get Tested! Get Cured!

Days to Hepatitis C Elimination.

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

To receive our weekly news updates in your inbox, CLICK HERE

Week Ending February 11, 2019

Goal to Eliminate HCV 2030 will be ‘narrowly’ missed
“As defined by WHO targets, the goal to eliminate hepatitis C virus globally by 2030 will be “narrowly missed,” but is possible by 2032 using new tools and “ambitious, integrated interventions,” study findings showed.”

OxyContin reformulation to curb opioid abuse led to hepatitis C surge, study finds
“Reformulation of the pain medicine OxyContin in 2010 to make it more difficult to abuse directly led to a large rise in hepatitis C infections as drug abusers switched from the prescription medication to injectable heroin, according to a new RAND Corporation study.”

A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C
“The hepatitis C virus is responsible for more deaths in the United States than any other infectious disease, and hepatitis C infections have been rising at an alarming rate since 2010. We evaluated the role of the opioid epidemic and, in particular, the 2010 introduction of an abuse-deterrent version of OxyContin.”

To tackle addiction, the French look beyond drugs to care for the person
“France finds that in order to reach people who use drugs, they first need to have a place where they’re comfortable enough to relax. This story is part of a series exploring harm reduction strategies and drug policies that have been successful in Western Europe.”

Sen. Wiener Reintroduces Bill Pushing For Safe Injection Sites
“State Sen. Scott Wiener, D-San Francisco, announced Monday he’s reintroducing state legislation that would allow San Francisco to implement safe injection sites–after a similar bill was vetoed last year by Gov. Jerry Brown.”

Hepatitis C Fight Hinges on Prisons
“Lawsuits across the country are seeking better but more expensive care for inmates with the infectious disease, who can spread it upon their release.”

AASLD/IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
“The landscape of treatment for hepatitis C virus (HCV) infection has evolved substantially since the introduction of highly effective HCV protease inhibitor therapies in 2011. The pace of change has increased rapidly as numerous new drugs with different mechanisms of action have become available over the past few years.”

Comorbid Hepatitis B, Hepatitis C in New Cancer Patients Often Undetected
“A significant number of patients with newly-diagnosed cancer and concurrent hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are unaware of their viral infection at the time of cancer diagnosis, according to study results published in JAMA Oncology.”

DEVELOPMENT AGAINST HEPATITIS C IS POSSIBLE BY 2030
“A complete package of screening, prevention, and treatment interventions can turn away 1.5 Million liver cancer and cirrhosis as well as 15.1 Million new hepatitis C infections deaths all over the world by end of 2030. This is equal to an 80% drop in occurrence and a 60% drop in deaths in comparison with 2015, as per the first research to model interventions of hepatitis C all over the world post in The Lancet.”

Washington state becomes the latest to embrace a Netflix model for buying hep C drugs
“The so-called Netflix payment model for obtaining hepatitis C treatments appears to be catching on among state officials as a Washington state health agency is the latest one hoping to convince drug makers to participate in such a scheme.”

Impact of Hepatitis C Virus and Insurance Coverage on Mortality
“To assess the association of payer status and mortality in hepatitis C virus (HCV)–infected patients.”

Week Ending February 11, 2019

From One Cancer to Many: How NSCLC Treatment Has Changed in 20 Years
“Reflecting on the past 20 years of advances in non–small cell lung cancer (NSCLC), I am struck by how long a period went by with so little progress. Of course, today NSCLC treatment is changing at a breakneck pace, with new advancements presented at seemingly every major meeting and newly approved drugs emerging multiple times per year.”

Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy
“Despite the benefits of first and second generation anaplastic lymphoma kinase (ALK) inhibitors in the management of ALK-rearranged advanced non-small-cell lung cancer (NSCLC), the development of acquired resistance poses an ongoing dilemma.”

Q&A: A new focus on small cell lung cancer
“Dr. David MacPherson discusses the state of small cell lung cancer research, how his lab is tackling this deadly disease, and what makes him excited for the future”

Researchers analyze efficacy and toxicity of ICIs in older patients with NSCLC
“Older adults with advanced non-small cell lung cancer (NSCLC) may be particularly vulnerable to adverse events, therapy discontinuation, glucocorticoid rescue, and hospitalization during treatment with immune checkpoint inhibitors (ICIs), according to a recent study published in the Journal of the American Geriatrics Society.”

Study: Lung Cancer Risk Drops Dramatically Within 5 Years Of Quitting Smoking
“The sooner you put out your final cigarette for good, the better. A study finds that the risk of lung cancer drops significantly within five years of quitting smoking.”

Simulating your cancer treatment on a computer
“In ten years, computers will be able to propose the most suitable cancer treatment for you. The idea is to simulate how all possible combinations of existing cancer treatments will work on your particular tumour.”

Expert Highlights Current Treatment Approaches in EGFR+ NSCLC
“Although immunotherapy has challenged the thought process behind treating many solid and hematologic tumors, physicians should proceed with caution when using these agents in patients with non–small cell lung cancer (NSCLC) who have driver mutations, such as EGFR, explained Rogerio Lilenbaum, MD.”

Padda Discusses Progress With Osimertinib and Next Steps in EGFR+ NSCLC
“Osimertinib (Tagrisso) has effectively overcome the T790M resistance mechanism associated with earlier-generation EGFR TKIs, but patients with EGFR-positive non–small cell lung cancer (NSCLC) are still experiencing disease progression on the third-generation drug, said Sukhmani Padda, MD.”

Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition
“Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with no targeted therapeutic options and in which chemotherapy is only partially effective. Previous studies indicated that SCLC growth is suppressed by drugs that inhibit the histone lysine demethylase LSD1.”

Doctors dramatically reduce racial disparities in early-stage lung cancer treatment
“Results from a study published in the journal Cancer Medicine show that a pragmatic system-based intervention within cancer treatment centers can eliminate existing disparities in treatment and outcomes for black patients with early-stage lung cancer across the U.S.”

Patients’ Satisfaction With Chemotherapy Influences Health-Related Quality of Life in Advanced Thoracic Cancer
“According to results of a Dutch prospective study of patients with locally advanced or metastatic thoracic cancer receiving chemotherapy with pemetrexed, lower patient satisfaction with treatment was associated with lower health-related quality of life (HRQoL) scores and higher frequencies of low-grade adverse events. This study was published online in Supportive Care in Cancer.”

Lung Cancer May Be Sniffed Out Earlier with Graphene e-Nose
“Lung cancer may not be the first thought that crosses the mind when talking about breathalyzer tests. But, what if lung cancer detection were as easy as breathing into a device? That is the goal of a group of researchers from the University of Exeter who have recently taken a new approach to e-nose technology integrated with multi-layered graphene for early detection of lung cancer.”

VIDEOS
For EGFR- and ALK-Driven Lung Cancers, Use ‘Best Drug First’

Week Ending February 11, 2019

Healthy diet can ease symptoms of depression
“An analysis of data from almost 46,000 people has found that weight loss, nutrient boosting and fat reduction diets can all reduce the symptoms of depression.”

Almost All U.S. Teens Falling Short on Sleep, Exercise
“Too little sleep. Not enough exercise. Far too much “screen time.” That is the unhealthy lifestyle of nearly all U.S. high school students, new research finds.”

Medical Students Can Benefit from a Steady Diet of Nutrition Training
“About half of all American adults have one or more preventable, diet-related chronic diseases, including cardiovascular disease, Type 2 diabetes and obesity, according to the U.S. Department of Health and Human Service and U.S. Department of Agriculture, as well as the Centers for Disease Control and Prevention.”

Study reveals complementary medicine use remains hidden to conventional medicine providers
“Research reveals that 1 in 3 complementary medicine (CM) users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.”

Time for a “Detox”? The Science Says No  
“A variety of “detoxification” (“detox”) diets and regimens—also called “cleanses” or “flushes”—have been suggested as a means of removing toxins from your body or losing weight. Detoxification may be promoted in many settings and may also be used in naturopathic treatment.”